Leukemia

Successful Treatment of Chronic Myeloid Leukemia with Low-Dose Nilotinib

By Eric Haigh, BS; Kamran Darabi, MD

Chronic Myeloid Leukemia, Leukemia

To our knowledge, cases of successful treatment of chronic myeloid leukemia (CML) with low-dose nilotinib (Tasigna) have not been reported. The following case represents our experience with a patient with CML who achieved good response to nilotinib therapy. Read More ›

Page 6 of 6

1
2
3
4
5
6

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

TON Print Edition

TON Weekly e‑Newsletter

I have reviewed and consent to the terms of TON's Privacy Policy, and TON has my permission to retain my information in its database, and to forward pertinent communications to me.